Can SpaceX Become a Millionaire-Maker Stock?

SpaceX is reportedly pursuing an IPO valuation of $1.75 trillion to $2 trillion, which would make it one of the world’s most valuable companies. The article highlights strong fundamentals, including an estimated $15 billion to $16 billion in 2025 revenue, $8 billion in EBITDA, and projected 2026 revenue of $20 billion with $14.2 billion in EBITDA. However, it argues the stock may be too expensive for most investors to realistically turn a small stake into $1 million at that valuation.

Analysis

The market is likely underestimating the signaling effect of a SpaceX IPO on the broader private-markets complex. A marquee listing at a trillion-plus valuation would not just reprice venture assets; it would also pull forward monetization timelines for late-stage hardware, defense-tech, and AI infrastructure names that have relied on private funding at ever-higher marks. That tends to create a short, sharp window where public-market comparables get bid first, while second-order beneficiaries are the exchange, IPO-adjacent banks, and asset managers with exposure to private secondary liquidity.

The harder read is valuation discipline. At the implied multiple set out here, the stock would need to behave like a durable monopoly compounder for years to justify downside protection, yet the business mix is still exposed to launch execution, launch cadence volatility, and capex intensity that can compress margins quickly if Starship timelines slip. A high-quality top line can still be a bad stock if the public market decides the narrative has shifted from “scarce strategic asset” to “priced for perfection.”

For listed peers, the main implication is not direct competition but capital-allocation repricing. NVDA and INTC benefit if the market keeps rewarding infrastructure that enables frontier models and space-linked compute/connectivity demand; PLTR is more vulnerable because mega-cap private listings soak up attention and capital from the same “strategic AI” bucket, which can temporarily compress multiples for adjacent story stocks. AVGO sits in the middle: any durable rise in satellite broadband and edge connectivity can support networking and custom silicon demand, but the stock is already priced for continued AI spend and has less room for multiple expansion.

The contrarian view is that a blockbuster IPO may actually be a near-term liquidity event for insiders rather than a clean public-market growth story. If initial float is tightly controlled, the stock could gap higher on scarcity, then underperform once lockup overhang and valuation gravity meet slower-than-advertised free-cash-flow conversion. That makes the setup more attractive for trading around catalysts than for buying and holding at launch.

Key Decisions for Investors

• Long NDAQ into any announced IPO timetable over the next 3-6 months; a flagship listing supports issuance volumes, but cap the position because the benefit is broad rather than single-name specific.
• Relative-value pair: long AVGO / short PLTR for the next 1-2 quarters; AVGO should benefit more from AI/edge infrastructure carry while PLTR is more exposed to multiple compression if private-market attention rotates away from public AI names.
• Avoid chasing a pre-IPO proxy basket of private-space names; wait for the first 30-60 days post-pricing, when scarcity premium is usually highest and downside from lockup/valuation reset is asymmetric.
• If exposed to private-markets funds, reduce position size into the IPO event; use the listing as a liquidity signal to harvest gains rather than assume unlimited mark-up persists.
• For higher risk tolerance, structure a call spread on NDAQ or AVGO rather than outright long; the upside is event-driven but the risk is that the market treats the IPO as isolated rather than a durable sector catalyst.